Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 7/20 | 0.47 |
| ▸ | PDE4A | P27815 | 5/20 | 0.47 |
| ▸ | PDE4C | Q08493 | 5/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 5/20 | 0.47 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.37 |
| ▸ | FEN1 | P39748 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.35 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27876715 | 0.81 | PDE4B (0.47) | PDE4BPDE4APDE4CPDE4DALDH1A1 | |
| SCHEMBL10455954 | 0.81 | ALDH1A1 (0.36) | PDE4BPDE4APDE4CPDE4DALDH1A1 | |
| SCHEMBL3643547 | 0.79 | NPC1 (0.54) | PDE4BPDE4APDE4CPDE4DALDH1A1 | |
| SCHEMBL4480101 | 0.79 | PDE4B (0.49) | PDE4BPDE4APDE4CPDE4DALOX5AP | |
| Bromide SCHEMBL20815552 | 0.79 | PDE4B (0.49) | PDE4BPDE4APDE4CPDE4DALDH1A1 | |
| SCHEMBL2492749 | 0.78 | PDE4B (0.47) | PDE4BPDE4APDE4CPDE4DALOX5AP | |
| SCHEMBL2464416 | 0.78 | LMNA (0.40) | PDE4BPDE4APDE4CPDE4DALDH1A1 | |
| SCHEMBL30516191 | 0.78 | LMNA (0.40) | PDE4BPDE4APDE4CPDE4DALDH1A1 | |
| SCHEMBL10868685 | 0.77 | APP (0.44) | ALDH1A1SMN1; SMN2KDM4EGAANPC1 | |
| SCHEMBL10457132 | 0.77 | LTA4H (0.40) | ALDH1A1SMN1; SMN2KDM4EMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0174174-B1 | A METHOD OF STABILISING HYDROXY-CONTAINING POLYMERS OF BUTADIENE OR SUBSTITUTED DERIVATIVES THEREOF | ELF ATOCHEM S.A. (FR) | 1990-05-23 | — | — | EP | claimed |
| US-4593128-A | Using a di- or triphenylphosphine compound | ATLANTIC RICHFIELD COMPANY (US) | 1986-06-03 | — | — | US | claimed |
| EP-0174174-A2 | A method of stabilising hydroxy-containing polymers of butadiene or substituted derivatives thereof | ELF ATOCHEM S.A. (FR) | 1986-03-12 | — | — | EP | claimed |
| US-8129467-B2 | Curing accelerating compound-silica composite material, method for producing curing accelerating compound-silica composite material, curing accelerator, curable resin composition, and electronic component device | HITACHI CHEMICAL CO., LTD. (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20090062460-A1 | CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, METHOD FOR PRODUCING CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, CURING ACCELERATOR, CURABLE RESIN COMPOSITION, AND ELECTRONIC COMPONENT DEVICE | HITACHI CHEMICAL CO., LTD. (JP) | 2009-03-05 | — | — | US | disclosed |
| EP-0174174-B1 | A METHOD OF STABILISING HYDROXY-CONTAINING POLYMERS OF BUTADIENE OR SUBSTITUTED DERIVATIVES THEREOF | ELF ATOCHEM S.A. (FR) | 1990-05-23 | — | — | EP | disclosed |
| US-4593128-A | Using a di- or triphenylphosphine compound | ATLANTIC RICHFIELD COMPANY (US) | 1986-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062460-A1 | CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, METHOD FOR PRODUCING CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, CURING ACCELERATOR, CURABLE RESIN COMPOSITION, AND ELECTRONIC COMPONENT DEVICE | NCAPH, RAD51, H1-2 | PDE4B 4764/4885PDE4A 4781/4885PDE4C 4802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.